Funding for this research was provided by:
National Cancer Institute (R01CA239548, R01CA195527, R01CA168575, R01CA148994)
National Science Foundation (CNS-1837572)
Received: 22 September 2021
Accepted: 22 February 2022
First Online: 5 March 2022
: The Research involved human participants. The study received institutional review board approval (IRB#: 12–003329 and IRB#: 19–003028.) and was Health Insurance Portability and Accountability Act (HIPAA) compliant. All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Signed IRB approved informed consent with permission for publication was obtained from all individual participants included in the study.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article, and the authors affirm that they do not have any potential financial interest related to the technology referenced in this paper.